Gamma scintigraphic evaluation of the fate of hydroxypropyl methylcellulose capsules in the human gastrointestinal tract

European Journal of Pharmaceutical Sciences

Volumn 21, Issue 5, 2004, Pages 671-678

  Honkanen, Outi ^a   Marvola, Janne ^a   Kanerva, Hanna ^b   Lindevall, Kai ^b   Lipponen, Maija ^c   Kekki, Tommi ^c   Ahonen, Aapo ^d   Marvola, Martti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Remedium Ltd   (Finland)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adherence; Gamma scintigraphy; HPMC capsule; Hydroxypropyl methylcellulose; Oesophagus; Prolonged release

Indexed keywords

GELATIN; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; METHYLCELLULOSE; METOCLOPRAMIDE;

ADHESION; ADULT; ARTICLE; ASCENDING COLON; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CAPSULE; DRUG FORMULATION; ESOPHAGUS; GAMMA SCINTIGRAPHY; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; INTESTINE TRANSIT TIME; LARGE INTESTINE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VISCOSITY;

ADULT; CAPSULES; DRUG EVALUATION; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINAL ABSORPTION; MALE; METHYLCELLULOSE; STATISTICS, NONPARAMETRIC;

EID: 1842502888     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2004.01.008     Document Type: Article

References (19)

1. Adkin D.A., Davis S.S., Sparrow R.A., Wilding I.R. Colonic transit of different sized tablets in healthy subjects. J. Controlled Release. 23:1993;147-156.
2. Bailey R.T. Jr., Bonavina L., McChesney L., Spires K.J., Muilenburg M.I., McGill J.E., DeMeester T.R. Factors influencing the transit of a gelatin capsule in the esophagus. Drug Intell. Clin. Pharm. 21:1987;282-285.
3. Channer K.S., Roberts C.J.C. Antipyrine absorption after delayed oesophageal capsule transit. Br. J. Clin. Pharmac. 18:1984;250-253.
4. Davis S.S., Hardy J.G., Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut. 27:1986;886-892.
5. Harris D., Fell J.T., Sharma H.L., Taylor D.C. GI transit of potential bioadhesive formulations in man: a scintigraphic study. J. Controlled Release. 12:1990;45-53.
6. Honkanen O., Seppä H., Eerikäinen S., Tuominen R., Marvola M. Bioavailability of ibuprofen from orally and rectally administered hydroxypropyl methyl cellulose capsules compared to corresponding gelatine capsules. STP Pharma Sci. 11:2001;181-185.
7. Honkanen O., Laaksonen P., Marvola J., Eerikäinen S., Tuominen R., Marvola M. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding hard gelatine capsule formulations. Eur. J. Pharm. Sci. 15:2002a;479-488.
8. Honkanen O., Nordberg M., Eerikäinen S., Tuominen R., Marvola M. Bioavailability of metoclopramide from orally and rectally administered novel hydroxypropyl methylcellulose capsules containing different diluents: a comparison with corresponding gelatine capsules. STP Pharma Sci. 12:2002b;299-307.
9. Marvola M., Vahervuo K., Sothmann A., Marttila E., Rajaniemi M. Development of a method for study of the tendency of drug products to adhere to the esophagus. J. Pharm. Sci. 71:1982;975-977.
10. McCargar L., Crail D., Dansereau R., Myers W., Lane M. The in-vitro porcine adhesion model is not predictive of the esophageal transit of risedronate tablets in humans. Int. J. Pharm. 222:2001;191-197.
11. Newman S.P., Hirst P.H., Wilding I.R. New developments in radionuclide imaging for assessing drug delivery in man. Eur. J. Pharm. Sci. 18:2003;19-22.
12. Ogura T., Furuya Y., Matsuura S. HPMC capsules - an alternative to gelatin. Pharm. Tech. Eur. 11:1998;32-42.
13. Parker G., Wilson C.G., Hardy J.G. The effect of capsule size and density on transit through the proximal colon. J. Pharm. Pharmacol. 40:1988;376-377.
14. Perkins A.C., Wilson C.G., Blackshaw P.E., Vincent R.M., Dansereau R.J., Juhlin K.D., Bekker P.J., Spiller R.C. Impaired oesophageal transit of capsule versus tablet formulation in the elderly. Gut. 35:1994;1363-1367.
15. Perkins A.C., Wilson C.G., Frier M., Vincent R.M., Blackshaw P.E., Dansereau R.J., Juhlin K.D., Bekker P.J., Spiller R.C. Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations. Int. J. Pharm. 186:1999;169-175.
16. Santus G., Lazzarini C., Bottoni G., Sandefer E.P., Page R.C., Doll W.J., Ryo U.Y., Digenis G.A. An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur. J. Pharm. Biopharm. 44:1997;39-52.
17. Säkkinen M., Marvola J., Kanerva H., Lindevall K., Ahonen A., Marvola M. Scintigraphic verification of adherence of a chitosan formulation to the human oesophagus. Eur. J. Pharm. Biopharm. 57:2004;145-147.
18. Wilson C.G., Washington N., Greaves J.L., Kamali F., Rees J.A., Sempik A.K., Lampard J.F. Bimodal release of ibuprofen in a sustained-release formulation: a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake. Int. J. Pharm. 50:1989;155-161.
19. Wilson C.G., Washington N., Norman S., Greaves J.L., Peach J.M., Pugh K. A gamma scintigraphic study to compare oesophageal clearance of "Expidet" formulations, tablets and capsules in supine volunteers. Int. J. Pharm. 46:1988;241-246.